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ABSTRACT
Objective. The Outcome Measures in Rheumatology (OMERACT)  ultrasound  (US) working 
group (WG) operates research activities for the validation of US as an outcome 
measurement instrument according to  the Filter 2.0  framework
Methods. From the onset of the WG research in 2005 through now,  original publications  on 
definitions and scoring systems for pathophysiological manifestations and elementary 
lesions of various rheumatic disorders were reviewed
Results. Definitions and scoring systems according to new terminology  are provided
Conclusions. We have redefined  OMERACT definitions of US pathology and elementary 
lesions  as well as scoring systems which are now proposed  for OMERACT approval  for 
application in clinical trials 
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 INTRODUCTION
Since their introduction in 2005 [1], the use of the provisional ultrasound (US) definitions 
have become part of the fundamental Outcome Measures in Rheumatology (OMERACT) 
methodology for developing and validating  US as a disease outcome measurement 
instrument (OMI) across various domains including  inflammatory burden and structural 
damage [2,3]. 
In a seminal paper, the OMERACT ultrasound (US) working  group (WG) described  six  
provisional definitions of US lesions considered to represent a US core set of 
pathophysiological manifestations in rheumatic diseases [1]. The definitions were truly 
provisional, as at that time, a concurrent systematic literature review (SLR) highlighted the 
lack of consensus-based definitions in the existing literature [4].  
 Since then, iterative validation exercises have repeatedly shown US to be a reliable OMI for 
measuring (ir)reversible pathophysiological manifestations of RA, i.e., synovitis, 
tenosynovitis, or erosions [5,8]. Furthermore,  the OMERACT US WG has engaged in the 
validation of US as an OMI  by defining US manifestations of rheumatic disorders other than 
RA, including  osteoarthritis, spondyloarthritis, psoriatic arthritis, crystal-related 
arthropathies,  large vessel vasculitis,  Sjogrens disease, systemic lupus erythematosus as 
well as in juvenile inflammatory arthritis.  The validation process not only resulted in a 
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 refinement of the original US definitions for RA pathologies but also in defining new disease-
associated pathologies and corresponding elementary lesions. 
This report provides an overview of the WG activities and presents the new US definitions 
and scoring systems for synovitis, enthesitis, tenosynovitis, and tendon damage.
UPDATED DEFINITIONS
a. Synovitis 
Rather than defining a single entity, the initial definition included two elementary lesions, 
synovial effusion  and synovial hypertrophy. Either one, separate or combined, could indicate 
synovitis [1]. 
Following a stepwise validation process that comprised a Delphi exercise for developing 
consensual definitions of pathology and elementary lesions, web-based  and patient 
reliability exercises testing systematically the validity and the reliability of those lesions [5,6],  
a subtask force of the OMERACT US WG concluded that the old definition of synovitis was 
not sustainable.  The new definition of an US-detected synovitis encompasses the whole 
concept of synovitis, thereby delineating synovial hypertrophy in a semi-quantitative graded 
B-mode feature and a graded Doppler mode feature. The presence of a hypoechoic SH is 
mandatory for defining the presence of an US-detected synovitis and for grading Doppler 
activity. Furthermore,  the new definition lacks the elementary lesion synovial effusion,  
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 since it did not prove reliable and also was frequently detected in healthy subjects [5-7]. In 
addition, the group developed a synovitis scoring system (5-7) combining B-mode and 
Doppler mode, which demonstrated sensitivity to change in small and large joints [8]. The 
new synovitis definition is presented in Table 1, and the new definition of the related 
elementary lesion is reported in table 2 . The combined EULAR-OMERACT scoring system is 
reported in the supplementary table 1.
b. Enthesitis  
Whereas the provisional US definition spoke of  enthesopathy [1], this term is now singled 
out  exclusively for a mechanically-related tendinopathy or enthesopathy including sports-
related activities [9,10]. 
Based on a SLR,  a high variability was found in the definition of enthesitis and in particular, 
its constituent elementary components and no consensus-based scoring existed [9]. This 
inhomogeneity resulted in an appropriate task force to work on the development of  a 
validated definition of enthesitis,  using the same methodology described for developing 
synovitis [10,11]. The final definition of enthesitis  is shown in table 1 and can  be used in 
SpA and PsA, along with the elementary lesions that should be detected for defining such a 
pathological entity (table 2) and the scoring system to use for grading these elementary 
lesion [11]. The scoring of Doppler was further refined in a recent Delphi exercise 
(unpublished data) obtaining >75% consensus on a semi-quantitative scoring 0-3 
(supplementary Table 2).
c. Tenosynovitis and tendon damage
Following the same systematic stepwise process, the OMERACT US WG conducted a series of 
formal Delphi studies and reliability exercises on elementary lesions of tenosynovitis and 
tendon damage, resulting in new definitions of tenosynovitis and related elementary lesions 
(table 1 and 2) as well as two scoring systems, one for tenosynovitis and one for tendon 
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 damage (supplementary table 3) [12,13].  Tendon damage is a structural lesion and solely 
defined  in B-mode, as this mode allows the evaluation of  the morphology. Criterion validity 
of the tendon damage definition was demonstrated in cadavers [14]. The new definition of 
tenosynovitis includes changes in B-mode and Doppler mode and has shown sensitivity to 
change in patients with RA [15]. 
d. Bone erosion
The original OMERACT definition of bone erosion spoke of an intraarticular discontinuity of 
the bone surface that is visible in two perpendicular planes [1].  As no new definition has 
been developed, this definition is still valid  (Table 1) [16]. Future research will focuss on  
distinguishing true RA- erosions from other cortical breaks, e.g. vessel channels.
e. Osteoarthritis (OA)
Initial activities on OA started as a joint venture between the OMERACT US WG and 
Osteoarthritis Research International and were mainly  focused on structural abnormalities  in 
hand OA. By testing the reliability of US in defining and grading cartilage lesions and 
osteophytes, the group produced a dichotomous and a four-grade semiquantitative score for 
cartilage damage and osteophytes, respectively (Table 2, supplementary table 3) [17,18].  
Following the work on hand OA,  the group targeted other joints  [19]. 
f. Juvenile idiopathic arthritis (JIA)
 Before defining synovitis in children, the JIA task force developed and validated definitions 
of normal joint components for different age groups through a Delphi consensus process 
and by testing them in a reliability exercise involving healthy children [20-23].  In contrast to 
the definition of synovitis in adults,  the US definition in children also includes synovial 
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 effusion [24]. The combined scoring system for synovitis using B-mode and PD mode  is 
presented in Supplementary Table 4. 
g.  Gout
 Following a SLR [25], the  group conducted a Delphi exercise with the aim of  obtaining and 
defining  the elementary components of  the gouty joint [26]. Four definitions of elementary 
lesions were highlighted, i.e., double contour,  aggregates, tophus and erosions (Tables 1,2) 
and subsequently tested for reliability in a patient-based exercise [27]. Future work will 
determine if these elementary lesions are reliable in the development of a scoring system.
h. CPPD disease
Although no therapeutic drugs have been specifically developed for treating calcium 
pyrophosphate crystal deposit (CPPD) disease, the WG  felt that CPPD related arthritis may 
be a confounding pathological manifestation. Following the OMERACT methodology, 
definitions of the US characteristics of CPPD at the level of fibrocartilage of the knee menisci 
and wrist, hyaline cartilage, tendons of the knee and synovial fluid of the knee were 
obtained  (Table 2, supplentary table 5) [28].  Subsequently, a  series of reliability exercises 
validated these elementary lesions [29].
i. Large vessel vasculitis (LVV)/giant cell arteritis (GCA) 
 The US appearance of normal  temporal and extra-cranial large arteries (e.g., axillary 
arteries) and of respective lesions in vasculitis was defined  [30](Table 2 ).  As a result of the 
consensus exercises, the halo sign and the compression sign are regarded as the most 
important US abnormalities for GCA [31]. 
DISCUSSION
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 US is a unique OMI for rheumatic disease processes as it is capable to capture both the 
inflammatory state and the structural damage. Starting from the 2005 preliminary 
definitions, novel US definitions have been developed and validated by the US WG. In 
accordance with the Filter 2.0, the validation process of an US definition follows a stringent, 
step-by-step roadmap which comprises  a SLR, a Delphi consensus process and patient 
reliability studies [2,3].  As the proof of the pudding is in the eating, responsiveness studies 
of US definition of synovitis and tenosynovitis have been carried out [8,15].  Along with 
progressive implementation of the OMI into clinical trials,  patient feedback will enforce 
refinement of the application of US, which is in agreement with the current  Filter 2.1.
The WG work is far from done. The bucket list now includes validating US as an OMI for 
monitoring disease activity in Sjogrens disease,  musculoskeletal involvement of lupus, 
dactylitis in PsA (which remains one of the most challenging concepts to reliably capture by 
imaging), cartilage involvement in RA, and scleroderma. As to dactylitis, a definition of 
paratendinitis is currently an ongoing work.
In addition to  the development and validation of new US definitions of different 
pathologies, further research needs to  delineate the (minimal) discriminatory threshold of 
these US pathologies. The first attempt will be to define the threshold of an active  synovitis 
in RA. Another important future activity will be the development of a reduced joint count 
based on the existing EULAR-OMERACT scoring system.  
In conclusion, we have redefined OMERACT  definitions of US pathology and elementary 
lesions   These updated definitions will provide clarity as we complete the validation of these 
criteria and scoring systems which are now proposed for approval for application in clinical 
trials. 
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Table 1. New OMERACT definitions of US-detected pathologies 
Synovitis Presence of a hypoechoic synovial hypertrophy regardless of 
the presence of effusion or any grade of Doppler signal 
Enthesitis Hypoechoic and/or thickened insertion of the tendon close to 
the bone (within 2 mm from the bony cortex) which exhibits 
Doppler signal if active and that may show erosions, 
enthesophytes/calcifications as sign of structural damage
Tenosynovitis Abnormal anechoic and/or hypoechoic (relative to tendon fibers) tendon sheath 
widening which can be related both to the presence of tenosynovial abnormal fluid 
and/or hypertrophy. Doppler signal can be considered if seen in two perpendicular 
planes, within the peri-tendinous synovial sheath, excluding normal feeding vessels 
(i.e. vessels at the mesotenon or vinculae or vessels entering the synovial sheath 
from surrounding tissues). Doppler mode should be used only if the tendon shows 
peritendinous synovial sheath widening on B-mode
Tendon damage Internal and/or peripheral focal tendon defect (i.e absence of fibers) in the region 
enclosed by tendon sheath, seen in two perpendicular planes; the grade of 
tendon damage should be assessed in both planes
Erosion Intra- and/or extra-articular discontinuity of bone surface (visible in two 
perpendicular planes)
Pediatric synovitis Presence of hypoechoic synovial hypertrophy or the presence of synovial effusion 
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Table 2. New definitions of the elementary lesions composing the  US pathologies
Pathology Inflammatory  elementary lesion Structural elementary lesion
Synovitis Synovial hypertrophy is defined as presence 
of abnormal hypoechoic synovial tissue 
within the capsule that is not displaceable 
and poorly compressible and that may 
exhibit Doppler signals
Enthesitis Increased thickness of tendon at enthesis
Hypoechoic tendon at enthesis
Doppler signal<2 mm from bony surface
Calcifications/enthesophytes 
at enthesis
Erosions at enthesis
Tenosynovitis Tenosynovial hypertrophy is defined as 
presence of abnormal hypoechoic (relative 
to tendon fibers) tissue within the synovial 
sheath that is not displaceable and poorly 
compressible, and seen in two 
perpendicular planes; it may exhibit 
Doppler signals
OA osteophytes Step-up bony prominence at the 
bony margin that is visible in two 
perpendicular planes
OA hyaline 
cartilage damage
Loss of anechoic structure and/or 
thinning of cartilage layer, and 
irregularities and/or sharpness of at 
least one cartilage margin
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Gout DC Abnormal hyperechoic band over 
the superficial margin of the 
articular hyaline cartilage, 
independent of the angle of 
insonation which may be either 
irregular or regular, continuous or 
intermittent and can be 
distinguished from the cartilage 
interface sign
Gout Tophus Circumscribed, inhomogeneous, 
hyperechoic and/or hypoechoic 
aggregation (which may or may not 
generate posterior acoustic 
shadow), which may be surrounded 
by a small anechoic rim
Gout Aggregates Heterogeneous hyperechoic foci 
that  maintain their high degree                        
of reflectivity, even when the gain 
setting is minimized or the 
insonation angle is changed and 
which occasionally may generate 
posterior acoustic shadow 
CPPD 
fibrocartilage
Hyperechoic deposits of variable 
shape, localized within the 
fibrocartilage structure, that remain 
fixed or move along with the 
fibrocartilage during dynamic 
assessment
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CPPD hyaline 
cartilage
Hyperechoic deposits of variable size 
and shape, without posterior 
shadowing, localized within the 
hyaline cartilage, that remain fixed 
and move along with the hyaline 
cartilage during dynamic assessment 
CPPD tendon Hyperechoic, linear structure(s) 
generally without posterior 
shadowing, localized within the 
tendon and remain fixed and move 
along with the tendon during 
dynamic assessment
CPPD synovial 
fluid
Hyperechoic deposits of variable 
size, localized within the synovial 
fluid, without posterior shadowing, 
and mobile along with joint 
movement and probe pressure
Halo Sign Homogeneous, hypoechoic wall thickening, 
well delineated towards the luminal side, 
visible in two perpendicular planes, most 
commonly concentric in transverse scan
Compression Sign Thickened arterial wall remains visible 
under compression, i.e., the echogenicity 
contrasts hypoechogenic due to vasculitic 
vessel wall thickening in comparison to 
mid/hyperechoic surrounding tissue
Abbrevations. CPPD, calcium pyrophosphate deposit; DC, double contour; OA, osteoarthritis; 
US, ultrasound.
Page 19 of 20
A
cc
ep
te
d
 A
rt
ic
le
T
h
is
 a
cc
ep
te
d
 a
rt
ic
le
 i
s 
p
ro
te
ct
ed
 b
y
 c
o
p
y
ri
g
h
t.
 A
ll
 r
ig
h
ts
 r
es
er
v
ed
.
 Rheumatology
The Journal of on April 2, 2019 - Published by www.jrheum.orgDownloaded from 
Page 20 of 20
A
cc
ep
te
d
 A
rt
ic
le
T
h
is
 a
cc
ep
te
d
 a
rt
ic
le
 i
s 
p
ro
te
ct
ed
 b
y
 c
o
p
y
ri
g
h
t.
 A
ll
 r
ig
h
ts
 r
es
er
v
ed
.
 Rheumatology
The Journal of on April 2, 2019 - Published by www.jrheum.orgDownloaded from 
